INTRODUCTION
Cell-cell interactions, through paracrine signaling, play critical roles in the regulation of mammary morphogenesis. Although most of these interactions involve luminal to basal signaling ( 1 ), a recent study has shown that basal cells may regulate luminal progenitor activity during pregnancy and lactation processes through p63-neuregulin signaling ( 2 ) . Similarly, tumorigenesis is a multistep process involving acquired genetic and epigenetic alterations that generate individual cell populations with aberrant differentiation and proliferation potential. Intratumoral heterogeneity (ITH) has been considered one important factor in assessing a patient's initial response to treatment and selecting drug regimens to effectively increase tumor response rates ( 3, 4 ) . Understanding the molecular interactions between various subpopulations of tumor cells, as well as their interaction with the microenvironment, may provide new targets for treatment to help in eradicating both primary and recurrent tumors. Most studies have focused to date on the latter; that is, the interactions of tumor cells with the microenvironment, for example, tumorassociated fi broblasts, macrophages, endothelial cells, osteoblasts, etc. However, little is known about the importance of possible tumor cell-tumor cell and paracrine interactions that may be important within the intrinsic tumor cell population.
ITH has long been recognized from a pathologic point of view ( 5 ) and has been identifi ed at the molecular level in the past few years through large-scale transcriptome and genome analyses ( 6, 7 ) . ITH is thought to be generated through subclonal evolution during tumor progression ( 8 ) , with different clones displaying various capabilities of tumor propagation and responses to therapy (8) (9) (10) (11) (12) . Such variability within a tumor may be partially explained by the cancer stem cell (CSC) theory. Contrary to the monoclonal theory of cancer ( 5 ), the CSC theory has suggested that a subpopulation of CSCs [a.k.a. tumor-initiating cells (TIC)] can self-renew and differentiate along a particular lineage to generate the bulk of tumor "nonstem" cells ( 7 ) . Using a strategy of transplanting fl uorescenceactivated cell sorting (FACS)-sorted single cells from solid tumors into immunodefi cient mice, a small subpopulation of TICs has been identifi ed from a variety of solid tumors, including breast tumors ( 13 ) . The ability to form secondary mammospheres after plating the cells dissociated from primary spheres cultured on a nonadherent substratum also has been used as a surrogate for an in vivo stem cell self-renewal assay ( 14 ) . The mammosphere and stem cell subpopulations have been shown to be more resistant to chemotherapy and radiation treatment than the total cells and non-stem cells, respectively (15) (16) (17) . This has been hypothesized to result in cancer recurrence and metastasis after the initial treatment.
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Although the CSC theory may apply in many subtypes of cancer, including breast cancer, increasing evidence has suggested non-TICs, although less tumorigenic than the TICs, may generate aggressive TICs within a tumor ( 18 ) . Li and Clevers ( 19 ) have proposed a theory of coexistence of both active and quiescent stem cells in several tissues as both cycling yet long-lived populations of stem cells have been identifi ed. However, "gold standard" limiting dilution transplantation assays most commonly used in the characterization of stem cells from various tissues might only identify active (cancer) stem cells. Therefore, investigation of ITH will provide important insights into the roles of stem cells as well as their interactions with other tumor cells in tumor initiation, progression, and treatment resistance.
Our previous studies defi ned a lineage-negative (Lin
hi subpopulation of TICs by both limiting dilution transplantation and in vitro mammosphere assays using a syngeneic Trp53 -null mouse mammary tumor model ( 20 ) . Using FACS and microarray analysis, these studies also identifi ed a unique group of cells in these tumors expressing "mesenchymal-like" cell markers. Factors such as cytokines, chemokines, growth factors, and secretory WNT proteins that have been reported to function as niche components in various tissues were signifi cantly increased within the mesenchymal-like tumor cell subpopulation. The stem cell niches characterized to date in the mouse use WNT signaling, NOTCH signaling, IL6, or CXCL12 to regulate stem cell function ( 21 ) . All of these factors are important autocrine or paracrine cues that affect diverse processes in normal tissue development and tumorigenesis. The functional interaction between niche cells and TICs, therefore, was investigated by comparing the properties of the combined "mesenchymal-like" and TIC subpopulations to the individual isolated subpopulations alone. Cocultures and Transwell cultures of putative niche cells with TICs in serum-free suspension mammosphere assays revealed that both the in vitro self-renewal ability and the proliferation potential of the TICs were enhanced in the presence of the niche cells or factors secreted from the niche cells. In vivo cotransplantation assays indicated that the niche cells enhanced the TIC tumor initiation potential when a limited number of TICs was present. Transduction of niche cells with lentiviral expressed short hairpin RNAs (shRNA) directed against differentially expressed Wingless-type MMTV integration site family, member 2 ( Wnt2 ) and Cxcl12 within the niche population resulted in reduced mammosphere frequency and decreased in vivo tumorigenic potential with increased latency. Knockdown of the receptors for these ligands in the TIC subpopulation also provided additional evidence of the importance of functional interactions between these tumor subpopulations. 
RESULTS

A
CD24
hi subpopulation displayed a signifi cantly increased tumorigenic potential as compared with the other subpopulations ( 20 ) . PCR genotyping performed using p53 primers (X7/X6.5 defi ning Trp53 wild-type, and X7/NEO19 defi ning Trp53 -null) confi rmed the Trp53 -null status of all the individual subpopulations, suggesting their non-host cell of origin when 30 cycles of PCR were performed ( Supplementary Fig. S1A, left) . A small trace of Trp53 wild-type product was detected when 35 cycles of PCR were performed, most likely due to infi ltrating immune cells within the tumors (Supplementary Fig. S1A, right) .
To determine whether there exist genomic copy-number differences among the four subpopulations, we performed high-resolution mouse whole-genome bacterial artifi cial chromosome (BAC)-based comparative genomic hybridization (CGH) array that covers the entire mouse genome ( 22, 23 ) . The syngeneic BALB/c mouse tail DNA was used as a control. The chromosomal copy-number profi les performed on the four subpopulations of the Trp53 -null tumor did not show signifi cant variations ( Supplementary Fig. S1B) .
We lo cells with those of the other three subpopulations identifi ed an increased expression of genes encoding WNT proteins, including WNT ligands WNT2 and WNT9a, CXCL12, and IL6 in this subpopulation (Supplementary Table S1 ). Interestingly, the TICs in the Trp53 -null tumor T1, a squamous adenocarcinoma, expressed a higher level of Axin2 and Tcf7 , both of which encode known targets of WNT signaling as demonstrated by qPCR ( Fig. 1A and B ) , suggesting the possible interaction between the TICs and the CD29 hi CD24 lo cells. The expression of Fzd7 , encoding one of the WNT ligand receptors, and Cxcr4 , encoding the receptor for CXCL12, was also upregulated in the TIC population as compared with the non-TIC population ( Fig. 1C and D ) .
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showed that 8.6% ± 1.3% (mean ± SD) of TICs were in G 0 -G 1 phase ( Fig. 2Aa ) , whereas 21.5% ± 3.3% of CD29 hi CD24 lo cells were in the G 0 -G 1 phase ( Fig. 2Ab ) . A more detailed characterization of the 20% cells in the G 0 -G 1 phase showed that 17.4% ± 3.7% of the CD29 hi CD24 lo cells were in the G 0 -phase and 3.2% ± 0.3% in the G 1 -phase ( Fig. 2Ba and b (Supplementary Fig. S3A , G 0 -G 1 : 9.6% ± 2.1%; Supplementary  Fig. S3B , G 0 : 7.8% ± 1.9%), and CD29 lo CD24 lo cells (Supplementary Fig. S3C , G 0 -G 1 : 12.6% ± 1.9%; Supplementary  Fig. S3D : G 0 : 8.9% ± 1.6%), respectively. We further measured the proliferative potential of the individual populations after FACS and cytospin centrifugation followed by Ki67 staining. Although 60% of TICs ( Fig. 2Ca ) were proliferative, only 30% of CD29 hi CD24 lo ( Fig. 2Cb ) cells were Ki67-positive ( Fig. 2D ).
The CD29 hi CD24 lo Niche Population Has Features of Mesenchymal and Claudin-Low Signatures
Because several genes expressed in the CD29 hi CD24 lo niche population have been associated with cells undergoing an epithelial-to-mesenchymal transition (EMT), we performed a comprehensive analysis of the RNA expression profi les of the individual populations using previously identifi ed mesenchymal ( 24 ) and claudin-low gene signatures ( 25, 26 ) . This analysis strongly supports the observation that the CD29 hi CD24 lo population expresses mesenchymal markers ( Fig. 2Ea ) . The mesenchymal gene expression signature was highly correlated with the claudin-low tumor subtype, with the claudin-low subtype-defi ning signature showing high expression in the CD29 hi CD24 lo subpopulation that also displays an increased expression of EMT features ( Fig. 2Eb and c ) . lo cells (labeled with red fl uorescent cell linker dye, PKH 26) with TICs (labeled with green fl uorescent cell linker dye, PKH 67) in serum-free mammosphere assays generated both large and an increased number of mammospheres as compared with culturing the TICs or CD29
hi CD24 lo cells alone ( Fig. 3A and B ) . However, the coculture of TIC and CD29 lo cells did not result in increased mammosphere frequency, indicating the unique interaction between the TICs and CD29 hi CD24 lo cells ( Fig. 3B ). These results suggest that both the in vitro self-renewal ability and proliferation potential of the TICs are enhanced in the presence of the niche cells. To directly test this hypothesis, the levels of CXCL12 expression under different culture conditions were measured ( Supplementary Fig. S4 ). The levels of CXCL12 secreted by CD29 hi CD24 lo cells, cultured either alone or together with TICs, were signifi cantly higher than observed with TICs alone, indicating that CXCL12 is both regulated and functioning via a paracrine mechanism to promote the in vitro self-renewal ability of TICs.
Next, we used a Transwell assay to determine whether direct cell-cell contact or secreted factors are required to enhance the self-renewal potential of TICs when cultured under the serum-free condition. A 0.4-μm fi lter was used to prevent the passage of both cell types through the membrane. Under these conditions, TICs cultured with the putative niche cells resulted in an increased number ( Fig. 3C ), but not size, of mammospheres as compared with that of the TICs by themselves. A marginally signifi cantly (**, P = 0.051) higher mammosphere-forming effi ciency of TICs was observed in the presence of TICs and niche cells as compared with that in the presence of niche cells alone. This result suggests Figure 1 . qPCR analysis using p53-null tumors suggested that Axin2 (A), Tcf7 (B), Fzd7 (C), and Cxcr4 (D) were upregulated in TICs. Total RNA isolated from FACS-sorted subpopulations based on the expression of CD29 and CD24 were extracted using the RNA purifi cation kit as mentioned in the Supplementary Data Microarray Analysis. *, P < 0.01. hi CD24 lo cells, were transferred to growth factor-reduced Matrigel, branching structures were observed if the TICs were previously Transwell-cultured with the putative niche cells, whereas no branching structures were observed if they were Transwell-cultured with the TICs alone ( Fig. 3D ) , suggesting the secreted molecules from the niche cells were able to affect the differentiation potential of the TICs. 
Downregulation of Preferentially Expressed Genes in the Putative
) Inhibits the Self-Renewal of TICs
We next determined the functional role of secreted factors previously identifi ed by our microarray studies. Because WNT signaling and CXCL12 secretion are known to increase the self-renewal potential of TICs (27) (28) (29) , we hypothesized that repression of WNT2 and CXCL12 expression in the niche cells alone might be inhibitory. FACS-sorted CD29 hi CD24 hi TICs have increased expression of Fzd7 , Tcf7 , and Axin2 encoding components of the WNT signaling pathway as compared with the non-TICs ( Fig. 1 ). This fi nding is consistent with the previous studies showing the TIC subpopulation identifi ed using cell-surface markers (CD29 and CD24) overlapped with the active canonical WNT signaling cells identifi ed using a WNT reporter system ( 17 ) . We thus performed coculture experiments using different combinations of WNT reporter-marked TOP-GFP + TICs, and niche cells with Wnt2 shRNA knockdown. lo niche cells, and a mixture of TICs and niche cells were Transwell-cultured with dissociated TICs from the primary mammospheres in serum-free mammosphere medium under nonadherent conditions for 7 days. Mammosphere formation was determined and quantitated as above at day 7. *, P < 0.05; **, P > 0.05. D, mammospheres formed from the TICs after Transwell culturing with the TICs or niche cells were collected and transferred to the 8-well chamber slides precoated with growth factor-reduced Matrigel. Pictures were taken after 14 days. Scale bars, 50 μm. T1 tumor at levels ranging from 50% to 60% ( Fig. 4A and B ). Genetically modifi ed knockdown niche cells were then cocultured with TICs in serum-free mammosphere medium under nonadherent conditions for 7 days. A reduced mammosphere-forming ability was observed for both knockdowns, indicating that the functional interaction between two cell types was disrupted, and the self-renewal potential of the TICs was inhibited ( Fig. 4C and D ).
Downregulation of Fzd7 and Cxcr4 in the TICs (CD29 hi CD24 hi ) in Combination with Downregulation of Wnt2 and Cxcl12 in the Niche Cells Signifi cantly Inhibits the In Vitro Self-Renewal of TICs
A higher expression of Fzd7 in the WNT-responsive TIC population than in the non-TIC population has suggested that FZD7 may play a role in the interaction of TICs with the surrounding cells through WNT signaling. To determine the functional interaction between TICs and niche cells, Fzd7 and Cxcr4 , Wnt2 and Cxcl12 , were knocked down, respectively, in the TIC and niche population, and their in vitro self-renewal potential was analyzed using mammosphere assays. Both Fzd7 and Cxcr4 expression were decreased by 75% and 55%, respectively, in the TICs as confi rmed by qRT-PCR ( Fig. 4E and F ) . When genetically modifi ed TICs and niche cells were cocultured, a signifi cant decrease of the mammosphere-forming ability was detected in both knockdowns, with the coculture of the knockdown in both TIC and niche populations exhibiting a greater reduction of mammosphere-forming ability as compared with the ligand knockdown alone ( Fig. 4G and H ) . In addition, when Il6 was knocked down in the niche cells (Supplementary Fig. S5A ), and such modifi ed niche cells were cocultured with TICs, a decrease in mammosphere-forming effi ciency was observed ( Supplementary Fig. S5B ).
CD29 hi
CD24 lo Niche Cells Enhance the TICs Tumor-Initiation Potential as Shown by Limiting Dilution Cotransplantation Assays
These in vitro assays were suggestive of a functional interaction between the TICs and niche cells. This was confi rmed using an in vivo limiting dilution analysis. Transplantation of 10 CD29 hi CD24 lo niche cells alone did not initiate tumor formation, whereas in contrast, at least 10 TICs were capable of initiating tumor formation ( Table 1A and Table S2 ). However, transplantation of 2 TICs, with a tumor formation frequency of 2 of 8, was able to initiate tumorigenesis when cotransplanted with 10 niche cells. Cotransplantation of increasing numbers of niche cells resulted in increasing numbers of tumors (Supplementary Table S3 and Fig. 5A ). This limiting dilution analysis involving several doses of TICs revealed signifi cant differences between groups defi ned by the numbers of niche cells: The time to tumor formation curves were also estimated and compared ( Fig. 5B ) . Across all eight groups, there was a signifi cant difference between groups ( P < 0.001). Two groups (TICs = 0/Niche = 10 and TICs = 5/Niche = 0) did not have any tumors, but differences remained signifi cant even after eliminating these two groups ( P = 0.002). For fi xed numbers of niche cells (i.e., niche cells = 10), tumor latency was decreased with increasing numbers of TICs (Supplementary Table S4A To determine whether the in vivo tumor-initiating ability of TICs was affected when secreting factors were repressed, we also cotransplanted the genetically modifi ed (shRNA ( Table 1 and Supplementary Table  S2 ). With 10 WNT-responsive TICs, different types of niche cells were associated with different tumor-forming frequencies (see Supplementary Table S5 with P value of 0.03 and Fig. 5C ). shRNA knockdown resulted in about a 4-fold decrease in tumor-forming frequency, as compared with the control shRNA.
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Kaplan-Meier curves were also generated for TICs = 10 groups in Table 1 ( Fig. 5D ) . Across all eight groups, there is a signifi cant difference between groups ( P < 0.001). To test whether shRNA niche cells reduced the time to tumor formation relative to the control shRNA, four comparisons were undertaken. There was no difference observed between shRNA groups for 0 or 2 niche cells, a marginal difference for 10 niche cells, and a signifi cant difference detected for 20 niche cells (Supplementary  Table S6A -S6D).
In summary, limiting dilution analyses and, alternatively, tumor latency analyses show that niche cells increased both the incidence and decreased the latency of tumor formation in a dose-dependent manner, and futhermore, that shRNA knockdown of Wnt2 reduced tumor formation, most noticeably in the presence of increased numbers of niche cells.
DISCUSSION
ITH correlates with clinical outcome ( 30 ) , which also poses considerable challenges for tumor prognosis and therapy ( 31 ) . Increasing evidence has emerged to show that various subpopulations of cells within solid tumors may respond differently to both conventional and targeted therapies. In a clinical study, residual breast cancer cells following treatment with either an aromatase inhibitor or chemotherapy showed an enrichment of the TIC subpopulation ( 32 
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infl uence tumor development. However, the mechanisms by which the different types of tumor cells interact with each other during tumor progression remain to be elucidated. Similarly, using the combined analyses of cellular differentiation markers (CD24, CD44, HER2, etc.) and genotypic alterations such as copy-number variation, Park and colleagues ( 34 ) uncovered a high level of genetic heterogeneity between stem-like cells and more differentiated cancer cell populations. These results questioned the validity of a unidirectional simple differentiation stem cell hierarchy. Therefore, the elucidation of the dynamic and functional relationship between various breast tumor cells may provide new therapeutic targets for drug development with the goal of both preventing breast cancer and reducing relapse and metastasis.
Using in vitro coculture, Transwell culture, and in vivo cotransplantation together with shRNA knockdown, we identifi ed a group of mesenchymal-like tumor cells from the Trp53 -null mammary tumors. Factors that have been reported to function as niche components in various tissues, such as cytokines, chemokines, and secretory WNT proteins, were signifi cantly increased within our mesenchymal-like cell subpopulation. WNT2 expression has been detected at high levels in both epithelium and stroma in infi ltrating carcinomas and fi broadenomas, indicating that an autocrine WNT signaling loop might exist within the tumor cells ( 35 ) . Stem cells may generate their own niche or interact with the surrounding microenvironment via WNT signaling ( 36 ) . We have demonstrated a marked overlap of the WNT-positive cells with the TIC population characterized as CD29 hi CD24 hi using a WNT reporter system ( 17 ). Consistently, a decreased self-renewal potential of the TICs when cotransplanted with the niche cells that were transduced with shRNAs mediating knockdown of Wnt2 indicated that the functional interaction between the TICs and the niche cells was disrupted. Thus, these various cell types functionally interact with each other using a mechanism similar to that used in the normal mammary gland. CXCL12 together with its receptor CXCR4 constitutes the chemokine-receptor axis that plays an important role in mammary tumorigenicity and metastasis ( 37 ) . The interaction between CXCL12 and CXCR4 also plays an important role in maintaining the hematopoietic stem cell pool in the bone marrow ( 38 ) . CXCL12 is also expressed in the cytoplasm of malignant ovarian epithelial cells ( 39 ) . In our study, the ligand CXCL12 and its receptor, CXCR4, are highly expressed, respectively, in the tumorderived niche cells and the TICs, suggesting the possible interaction between TICs and the mesenchymal-like niche. Therefore, the knockdown of both Cxcr4 in the TICs and the Cxcl12 in the niche subpopulation were performed to investigate the role of CXCL12 and CXCR4 in the interaction of our various tumor cells. The reduction in the mammosphereforming effi ciency when Wnt2/Fzd7 were knocked down was not as dramatic as that in the Cxcl12/Cxcr4 knockdown ( Fig. 4G and H ) , although the expression level of Fzd7 was decreased by 70% as compared with 50% for Cxcr4 ( Fig. 4E  and F ). This may be partially due to the presence of multiple redundant ligand/receptor components for WNT signaling as compared with the specifi c interaction between CXCL12 and CXCR4. Our data also support a role for IL6 in TIC self-renewal as demonstrated by the reduced mammosphere-forming ability observed following Il6 knockdown. These results are consistent with previous fi ndings that IL6 regulates the breast TIC population through both autocrine and paracrine mechanisms ( 40, 41 ) . Tumor cells have been shown to secrete IL6 to promote tumor growth ( 42 ) via an autocrine mechanism. It is also likely that the TICs produce factors that regulate the mesenchymal population. However, the level of CXCL12 secretion was extremely low when TICs were cultured alone, suggesting that a potential paracrine feedback pathway regulating CXCL12 expression may be important in this tumor model. Both tumor formation frequency and tumor latency time after limiting dilution transplantation experiments refl ect the process of tumor initiation, with the formation frequency representing the relative number of stem cells and/or the ability of the cell population to establish a niche to allow replication, whereas tumor latency represents the proliferative potential of these cells. In vivo cotransplantation demonstrated that such niche cells enhanced TIC tumor initiation, likely by providing an improved microenvironment, especially for those tumors initiated from extremely low numbers of TICs. The shortened latency observed in the presence of niche cells is consistent with the fi ndings that WNT signaling promotes cell proliferation ( 43 ) .
Although studies have suggested that there is a dynamic equilibrium among various cell subpopulations, the relevance of this "plasticity" in infl uencing treatment response, metastasis, and recurrence is unknown ( 44 ) . It remains to be determined what factors contribute to ITH in solid cancers, and if plasticity in these subpopulations contributes to treatment resistance, metastasis, minimal residual disease, and recurrence. 
One method to defi ne self-renewal and differentiation properties of CSCs is through limiting dilution transplantation to identify cells capable of forming tumors that recapitulate the characteristics of the original tumor. Our results suggest that Trp53 -null tumors contain cells with different degrees of selfrenewal capacity. Although cell plasticity may exist between TICs and non-TICs, a majority of the resulting tumor cells were derived from the TICs ( Supplementary Fig. S6 and Fig.  6 ; ref. 1 ). Mesenchymal cells resulting from an EMT are usually more migratory and less proliferative than their epithelial counterparts ( 45 ) . Thus, it is likely that the widely used limiting dilution transplantation assay may preferentially identify the rapidly proliferative TICs, but not the less proliferative, more quiescent population that may also initiate tumor growth. Previous limiting dilution transplantation assays have shown that the niche cell population is 30-fold less tumorigenic than the TICs ( 17 ) , and the niche cells, indeed, are more quiescent and less proliferative than the TICs. Notwithstanding these studies, in the absence of appropriate lineage tracing experiments, it is not feasible to defi nitively know the origin of these primary tumor cells. When TICs were cotransplanted with the mesenchymal-like tumor cells, the latter cells increased the self-renewal and tumorigenic potential of the TICs, causing the expansion of the TIC population, especially during early tumor development ( Fig. 6 ; ref. 2 ). CD29 hi CD24 lo cells fail to generate tumors with a low number of cells, and the resulting tumors exhibit a different phenotype and FACS profi le as compared with the TIC-derived tumors, suggesting that these cancer cell subpopulations may interact and collaborate differently with the host microenvironment. Interactions of self-renewing tumor cells with both the microenvironment and the surrounding tumor cells determine the progression and phenotypic features of the tumors. The generation of cells with less selfrenewal, but with mesenchymal features, was able to fuel tumor growth. Recently, using approaches including whole-genome sequencing and reverse phase protein arrays (RPPA), Li and colleagues ( 46 ) thoroughly characterized 13 patient-derived xenograft (PDX) lines along with their advanced primary breast tumors. The studies showed that although PDXs have relatively stable genomes without a signifi cant accumulation of DNA structural rearrangements, minor mutant clones are retained in PDXs during multiple transplants, indicating the possibility of cooperation of clones during tumor evolution. Further characterization of the individual subpopulations using PDX lines will help us better understand the complexity of human breast cancer. Eliminating multiple subpopulations and blocking the transition between these populations will be an important consideration when designing effective cancer therapies.
Only a limited number of studies to date have been able to demonstrate the importance of functional ITH. For example, Cleary and colleagues ( 47 ) reported recently that both the luminal and basal populations were required for effi cient tumor formation in the MMTV-driven WNT1 genetically engineered mouse model, which was dependent on luminal WNT1 expression. In this transgenic mouse model, Hras mutations were used as clonal markers identifying both distinct basal Hras-mutant and luminal wild-type tumor subclones. A similar requirement for WNT signaling was observed in our stochastic 
Trp53 -null BALB/c tumors that are also a model for basal-like breast cancer ( 25 ) . However, in the p53 model, a distinct TIC population has been identifi ed, and, as discussed previously, the interaction with the mesenchymal-like subpopulation enhanced, but was not essential for, tumor formation.
To better understand clonal heterogeneity, Marusyk and colleagues ( 48 ) recently developed an experimental model in which factors previously implicated in tumor progression were overexpressed in the indolent MDA-MB-468 cell line. These investigators then generated sublines expressing different cytokines and used these to model how subclonal cooperation was required for metastasis. These studies support the conclusion that there are non-cell-autonomous drivers of tumor growth, and importantly that interclonal interactions can lead to new phenotypic properties.
In our studies, no large-scale genomic deletions or insertions among individual subpopulations of CD29 lo cells were detected using CGH analysis. Therefore, in the Trp53 -null BALB/c tumors, it appears that epigenetic factors may infl uence clonal heterogeneity, and that ITH may not be exclusively due to genetic differences among various subpopulations. Thus, even when introduced into a similar microenvironment, epigenetic modifi cations may allow different clones to develop into cells with markedly different tumorigenic potential and phenotypes. DNA sequencing has demonstrated an increased mutation frequency in human triple-negative breast cancers as compared with ER-positive luminal breast cancers ( 49 ) , but many of these mutations occurred at low frequency. Therefore, it is likely that both genetic and epigenetic factors will play a role in generating ITH, and this may only be detected by indepth single cell sequencing. It is also likely that the stochastic tumors resulting in the germline Trp53 -null mouse model are under different selection pressures from those observed in somatic Trp53 -null and mutant human breast cancers.
METHODS
Materials
TOP-eGFP and its control vector, FOP-eGFP, were kind gifts from Dr. Irving Weissman (Stanford University, Stanford, CA). pEIZsGreen and pEITomato Red vectors were kindly provided by Dr. Bryan Welm (Oklahoma Medical Research Foundation, Oklahoma City, OK). The highly transfectable 293T cell line, which was used routinely for virus propagation, was purchased from the ATCC. No test and authentication was done by the authors. All other antibodies, lentiviral particles, and primers were purchased from commercial sources as listed in the Supplementary Data Materials and Methods.
Preparation of Single Mammary Tumor Cells
Mice were maintained in accordance with the National Institutes of Health Guide for the Care and Use of Experimental Animals. All animal protocols were reviewed and approved by the Animal Protocol Review Committees of the University of Pittsburgh (Pittsburgh, PA) and Baylor College of Medicine (Houston, TX). Trp53 -null mammary tumors were generated as previously described ( 20 ) .
Mammosphere and Transwell Coculturing Assays
The protocol for mammosphere assays was as described by Dontu and colleagues ( 14 ) and in the Supplementary Data. For mammosphere coculture, 5,000 TICs, 5,000 CD29 hi CD24 lo niche cells, or 2,500 TICs plus 2,500 niche cells, 2,500 TICs plus 2,500 CD29 lo cells, or 2,500 TICs plus 2,500 niche cells with Cxcl12 or Wnt2 knockdown, and 2,500 TICs with Cxcr4 or Fzd7 knockdown plus 2,500 niche cells were cultured after dissociation of the primary mammospheres in 2 mL serum-free mammosphere medium under a nonadherent condition for 7 days. PKH26 (red fl uorescent) and PKH67 (green fl uorescent) cell linker kits (Sigma) were used to label individual cell subpopulations according to the manufacturer's protocol.
For Transwell culture of mammospheres, 5,000 TICs, 5,000 CD29 hi CD24 lo niche cells, or 2,500 TICs plus 2,500 niche cells were Transwell-cultured with 5,000 dissociated TICs after dissociation of the designated cell types from the primary mammospheres in 3.6 mL serum-free mammosphere medium under a nonadherent condition in Transwell plates for 7 days.
Lentiviral Transduction
Lentiviral transduction was performed as described previously ( 17 ) . The pEIZsGreen and pEITomato Red lentivirus reporters were driven by an EF1α promoter, and the lentiviruses were packaged in 293T cells by cotransfection of pEIZsGreen (or pEITomato Red), pRSV-rev, pMDLg-pRRE, and pCMV-VSVG using Fugene transfection reagent (Roche). For fl uorescence tracking, enzymatically digested and FACS sorted Trp53 -null tumor cells (niche cells or TICs; 20,000/per well)
were suspended into 24-well ultra-low attachment plates, and transduced with lentiviruses expressing either pEIZsGreen or pEITomato Red, allowing stable integration of ZsGreen and Tomato Red fl uorescence reporter at a multiplicity of infection (MOI) of 10, respectively, for 24 hours in a fi nal volume of 1 mL serum-free mammosphere medium. After transduction, ZsGreen or Tomato Red-positive cells were FACS-sorted and collected in Hank's Balanced Salt Solution (HBSS) medium, before transplantation.
For knockdown analysis, dissociated and FACS-sorted TICs and niche cells from the Trp53 -null tumors (20,000/per well) were suspended into 24-well ultra-low attachment plates, and were transfected with empty shRNA vector control, panels of shRNA lentiviruses against Cxcr4, Fzd7, or two different Wnt2 shRNA lentiviruses, one Cxcl12 shRNA, and two different Il6 shRNA lenviruses, respectively, as designated in the main text, for 48 to 72 hours in a fi nal volume of 1 mL serum-free mammosphere medium. The shRNA sequences (antisense) used in this study are listed in the Supplementary Data. Cells infected with viruses were selected in the presence of 2 μg/mL of puromycin. Downregulation of the target genes was verifi ed by RT-PCR using TaqMan primer and probe sets (Life Technologies). Lentiviral pLKO.1 empty vector control (Dharmacon) was used as the control vector.
In Vivo Transplantation into the Cleared Mammary Fat Pad
Clearance of the mammary fat pad and transplantation procedures were performed as originally described ( 20 ) . For cotransplantation studies, FACS-sorted CD29 hi CD24 lo cells and TICs were mixed at designated numbers in HBSS medium.
FACS-sorted TICs and niche cells were also collected and transfected with lentiviruses as described in the Lentiviral Transduction section above. Then, these two populations of cells were mixed and cotransplanted into the cleared fat pads of 3-week-old female recipient mice (BALB/c mice from Harlan) at the designated ratios 
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mice. For all in vivo transplantation assays, 50% growth factorreduced Matrigel (BD Biosciences) was added to make the fi nal volume of 2 μL before injection. Two weeks after transplantation, tumor formation was monitored daily. Mammary tumor tissues were removed when tumor size reached 1 cm in diameter.
Quantitative Reverse Transcriptase-Polymerase Chain Reaction
RNA (300 ng each) was used to generate cDNA with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the company's protocol. qRT-PCR reactions were performed as described in the Supplementary Data.
Immunostaining and Microscopic Analysis
Paraffi n-embedded and paraformaldehyde (PFA)-fi xed tumor tissues, and FACS-sorted and cytospun cells were stained with the antibodies against K5 (1:5,000), SMA (1:250), and Ki67 (1:200) as described in the Supplementary Data. Microscopic analysis was done on an Olympus BMAX 50 fl uorescence microscope with details described in the Supplementary Data.
Microarray Analysis
Statistical analyses for microarray were performed in the biostatistics core facility of the Dan L. Duncan Cancer Center at Baylor College of Medicine (A. Tsimelzon), and University of North Carolina at Chapel Hill (Chapel Hill, NC; C. Fan). Detailed analysis was described in ref. 20 and in the Supplementary Data. The complete array data can be accessed at Gene Expression Omnibus (GEO; GSE8863).
Mesenchymal and Claudin-Low Signature Analysis on Individual Populations
RNA microarray data obtained from the four individual subpopulations (CD29   hi   CD24 hi , CD29 hi CD24 lo , CD29 lo CD24 hi , and CD29 lo CD24 lo ) were analyzed. Each signature/module was built using the median expression of the gene lists published in corresponding articles as referenced. Boxplots of the signatures were constructed and ANOVA analysis for the signatures in the four different groups was performed using the R software package. Three independent tumors from the Trp53 -null model were included in this analysis for each boxplot category. See related article by Zhang et al., p. 520 (6) .
Disclosure of Potential Confl icts of Interest
Although the heterogeneous cellular composition of tumors has been long appreciated, the biologic and clinical signifi cance of this cellular heterogeneity is becoming increasingly evident. In addition to genetic heterogeneity generated by mutation and clonal selection, it is now clear that epigenetic regulation also contributes to tumor cellular heterogeneity ( 1 ) . Epigenetic regulation mimicking normal differentiation contributes to the generation of hierarchically organized cellular clones that, although sharing common mutation profi les, express diverse gene expression patterns. At the apex of these hierarchies are populations of cells capable of self-renewal, as well as generating more differentiated cells constituting the tumor bulk. These "stemlike" cells are of clinical signifi cance because they mediate tumor metastasis and contribute to treatment resistance. Recent research has suggested that tumor stem cells display the plasticity to transition between alternative states, including a relatively quiescent, invasive, mesenchymal-like state (EMT) and a more proliferative epithelial-like state (MET; ref. 2 ). Furthermore, transition between these states is regulated by the tumor microenvironment, which plays an important role in tumor metastasis .
The tumor microenvironment is constituted by a multitude of nontumorigenic cells, such as mesenchymal stem cells, stromal cells, and a host of immune cells, including myeloid-derived suppressor cells and macrophages ( 3 ) . These cells form a specialized part of the tumor microenvironment termed the "cancer stem cell (CSC ) niche." Communication between stromal cells and CSCs in the niche has been well studied and is mediated by a variety of secreted and cell-cell contact factors that are critical for CSC function ( 4 ) .
Although most attention has been focused on the interaction between tumor cells and host cells in the tumor microenvironment, recent evidence suggests important roles for communication between heterogeneous populations of tumor cells. Marusyk and colleagues ( 5 ) demonstrated an important role for interclonal communication during mammary tumorigenesis. However, communication between CSCs and their progeny has been less well studied. In this issue, Zhang and colleagues ( 6 ) use a previously reported ( 7 ) syngeneic p53-null mouse model to examine the interactions between CD29 hi CD24 hi cells, which mark a bipotent, strongly tumor-initiating cell population, and more mesenchymal CD29 hi CD24 lo breast tumor cells. Microarray analysis of the CD29 hi CD24 lo population showed a strong mesenchymal and claudin-low gene expression signature and indicated that these cells displayed high expression of a number of secreted signaling molecules, including WNT2, WNT9A, CXCL12, and IL6. Interestingly, as assessed by qRT-PCR analysis, the CD29 hi CD24 hi population had signifi cantly higher expression of a number of members of the WNT signaling pathway, including AXIN2, TCF7, and FZD7, while also expressing high levels of CXCR4, the receptor for CXCL12. This strongly suggested that the CD29 hi CD24 lo population was secreting signaling molecules that were acting upon the CD29 hi CD24 hi CSCs, promoting their self-renewal. Because the CD29 hi CD24 lo mesenchymal cells were derived from the CD29 hi CD24 hi population, this suggests that CSCs are able to generate their own niche. In order to demonstrate the functional signifi cance of these secreted factors, the various cell populations were grown in coculture in Transwell plates. CD29 hi CD24
hi CSCs that were incubated with the mesenchymal CD29 hi CD24 lo niche population showed an increase in both effi ciency of mammosphere formation and sphere size and displayed an increased tumor-initiating capacity in mice. This increase in mammosphere formation effi ciency could be signifi cantly abrogated by shRNAs reducing expression of either WNT2 or CXCL12 in the CD29 A key element of the fi ndings of Zhang and colleagues is the positive feedback loop between cancer stem cells and mesenchymal tumor populations derived from them. As a result, these tumors produce high levels of WNT2, CXCL12, and IL6, which in turn drives the self-renewal of tumorinitiating cells, which then produce more mesenchymal cells, and so forth ( Fig. 1A ) . This might provide an explanation for the observation that basal and claudin-low breast tumors have the highest proportion of cancer stem cells ( 8 ) and are among the most aggressive and diffi cult to treat. This also emphasizes the importance of targeting both bulk and CSC populations to achieve maximum therapeutic effect. Moreover, signaling molecules involved in these feedback loops represent rational therapeutic targets. In fact, inhibitors of WNT, CXCR4, and IL6 have entered early-phase cancer clinical trials.
The work of Zhang and colleagues provides important new data on cell-cell communication in the cancer stem cell niche. However, a number of questions remain. These include further characterization of the CD29 hi CD24 lo mesenchymal niche cell population. Although described as mesenchymal niche-like cells, they in fact have tumor-initiating capacity, albeit less than the CD29 hi CD24 hi CSC population. Furthermore, tumors generated from this mesenchymal-like population are primarily epithelial rather than mesenchymal in nature. Together, this suggests that at least a fraction of the CD29 hi CD24 lo population is better characterized as an EMT-like CSC, rather than as a fi xed EMT-like cell. If this is the case, then it suggests that there may be interactions between different CSC populations that regulate their behavior, as illustrated in Fig. 1B . Further work will be required to determine the exact nature of these interacting cells.
The work of Zhang and colleagues adds to the growing body of literature demonstrating that CSCs are able to generate key components of their niche and that differentiated progeny may play important roles in CSC regulation. It has previously been demonstrated that the steroid hormones 
